EGFR and breast carcinoma: In these multitargeted genes, we observed significant enrichment in cancer‐associated pathways including Glioma Signalling (p = 1.38E‐07), IL‐3 Signalling (p = 8.56E‐06), Molecular Mechanisms of Cancer (p = 1.38E‐05), ErbB Signalling (p = 4.21E‐05), and Breast Cancer Regulation by Stathmin1 (p = 17.27E‐05) (Figure 2i), as well as enrichment in gene sets associated with Cancer and Inflammatory Response (Figure 2j).